Colgate-Palmolive Co. [NYSE: CL] closed the trading session at $88.76. The company report on March 12, 2024 at 1:00 PM that ZO® Skin Health Appoints Industry Veteran Justin Skala as CEO to Continue Strong Growth.
ZO® Skin Health, a premium clinical dermatological skincare brand distributed globally through physicians and skincare professionals, today announced the appointment of Justin Skala as Chief Executive Officer. Mr. Skala brings more than 35 years of leadership experience growing high efficacy products through the professional channel, including driving the expansion of the personal care category over his tenure at Colgate-Palmolive, Inc. (NYSE: CL). He succeeds Mark Williams who will continue to serve the company on its Board of Directors.
“Justin brings incredible experience fueling the growth of iconic personal care brands and successfully introducing innovative new products to market. His experience and commitment to serving patients with clinically efficacious regimens will be immensely valuable in driving continued growth at ZO® Skin Health,” said Board Chair Todd Hirsch. “We are grateful to Mark for his many contributions to the company over the years and look forward to continue working together in his role as a member of the Board.”.
The stocks have a year to date performance of 11.35 percent and weekly performance of 2.34 percent. The stock has been moved at 20.03 percent over the last six months. The stock has performed 6.35 percent around the most recent 30 days and changed 15.02 percent over the most recent 3-months.
If compared to the average trading volume of 4.86M shares, CL reached to a volume of 4251783 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Colgate-Palmolive Co. [CL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CL shares is $90.49 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CL stock is a recommendation set at 1.77. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Goldman have made an estimate for Colgate-Palmolive Co. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 01, 2024. The new note on the price target was released on January 29, 2024, representing the official price target for Colgate-Palmolive Co. stock. Previously, the target price had yet another raise to $90, while BofA Securities analysts kept a Buy rating on CL stock.
The Average True Range (ATR) for Colgate-Palmolive Co. is set at 1.10, with the Price to Sales ratio for CL stock in the period of the last 12 months amounting to 3.76. The Price to Book ratio for the last quarter was 119.72, with the Price to Cash per share for the same quarter was set at 1.39. Price to Free Cash Flow for CL in the course of the last twelve months was 24.03 with Quick ratio for the last quarter at 0.71.
CL stock trade performance evaluation
Colgate-Palmolive Co. [CL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.34. With this latest performance, CL shares gained by 6.35% in over the last four-week period, additionally plugging by 20.03% over the last 6 months – not to mention a rise of 24.47% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CL stock in for the last two-week period is set at 77.91, with the RSI for the last a single of trading hit 84.04, and the three-weeks RSI is set at 73.61 for Colgate-Palmolive Co. [CL]. The present Moving Average for the last 50 days of trading for this stock 83.62, while it was recorded at 88.06 for the last single week of trading, and 77.27 for the last 200 days.
Colgate-Palmolive Co. [CL]: An insightful look at the core fundamentals
Colgate-Palmolive Co.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.71 and a Current Ratio set at 1.11.
Earnings per share (EPS) analysis for Colgate-Palmolive Co. [CL] stock
With the latest financial reports released by the company, Colgate-Palmolive Co. posted 0.73/share EPS, while the average EPS was predicted by analysts to be reported at 0.7/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 4.30%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CL. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Colgate-Palmolive Co. go to 8.38%.
Colgate-Palmolive Co. [CL]: Institutional Ownership
The top three institutional holders of CL stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in CL stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in CL stock with ownership which is approximately 5.8325%.
